We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$24.5B
AUM Growth
+$1.31B
(+5.7%)
Cap. Flow
+$569M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
15.71%
Holding
3,091
New
800
Increased
1,401
Reduced
859
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$23.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$21M |
| 3 |
Microsoft
MSFT
|
+$20.5M |
| 4 |
Dow Inc
DOW
|
+$20.2M |
| 5 |
JPMorgan Chase
JPM
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$36.1M |
| 2 |
Pfizer
PFE
|
+$19.3M |
| 3 |
DuPont de Nemours
DD
|
+$17.8M |
| 4 |
AGNC Investment
AGNC
|
+$15.5M |
| 5 |
Intel
INTC
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 17.2% |
| 3 | Healthcare | 13.08% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Gorman-Rupp
GRC
$1.91B
| $187K | ﹤0.01% |
5,694
-410
| -7% | -$13.3K |
|
2202
Pacira BioSciences
PCRX
$993M
| $187K | ﹤0.01% |
+4,298
| New | +$182K |
|
|
SRDX
2203
DELISTED
Surmodics
SRDX
| $187K | ﹤0.01% |
+4,328
| New | +$183K |
|
|
AUD
2204
DELISTED
Audacy, Inc.
AUD
| $187K | ﹤0.01% |
32,383
-31,899
| -50% | -$196K |
|
2205
German American Bancorp
GABC
$1.85B
| $186K | ﹤0.01% |
+6,185
| New | +$182K |
|
2206
Huron Consulting
HURN
$2.45B
| $185K | ﹤0.01% |
+3,680
| New | +$180K |
|
2207
Dave & Buster's
PLAY
$239M
| $185K | ﹤0.01% |
4,571
+457
| +11% | +$23.2K |
|
|
UCTT
2208
Ultra Clean Holdings
UCTT
$3.01B
| $184K | ﹤0.01% |
13,220
+1,600
| +14% | +$20.4K |
|
2209
Virtu Financial
VIRT
$5.06B
| $184K | ﹤0.01% |
+8,435
| New | +$198K |
|
2210
Cavco Industries
CVCO
$4.13B
| $183K | ﹤0.01% |
+1,159
| New | +$158K |
|
2211
Cytokinetics
CYTK
$9.65B
| $183K | ﹤0.01% |
+16,271
| New | +$157K |
|
|
XIN
2212
DELISTED
Xinyuan Real Estate
XIN
| $183K | ﹤0.01% |
4,372
-1,583
| -27% | -$71.1K |
|
2213
Roku
ROKU
$23B
| $181K | ﹤0.01% |
+1,998
| New | +$160K |
|
2214
Heritage Insurance Holdings
HRTG
$1.04B
| $179K | ﹤0.01% |
+11,606
| New | +$171K |
|
|
LORL
2215
DELISTED
Loral Space and Communications, Inc.
LORL
| $179K | ﹤0.01% |
5,175
-5,713
| -52% | -$207K |
|
2216
Theravance Biopharma
TBPH
$884M
| $178K | ﹤0.01% |
10,932
-1,132
| -9% | -$22.9K |
|
|
RPT
2217
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $178K | ﹤0.01% |
14,681
-7,183
| -33% | -$88.6K |
|
|
EBSB
2218
DELISTED
Meridian Bancorp, Inc.
EBSB
| $178K | ﹤0.01% |
+9,941
| New | +$170K |
|
2219
Central Garden & Pet Co
CENT
$2.54B
| $177K | ﹤0.01% |
+8,195
| New | +$181K |
|
2220
Motorcar Parts of America
MPAA
$202M
| $177K | ﹤0.01% |
+8,267
| New | +$160K |
|
2221
Opko Health
OPK
$1.2B
| $177K | ﹤0.01% |
72,789
+12,631
| +21% | +$27.6K |
|
2222
NRC Health Common Stock
NRC
$488M
| $176K | ﹤0.01% |
+3,061
| New | +$142K |
|
2223
Hackett Group
HCKT
$273M
| $173K | ﹤0.01% |
+10,292
| New | +$166K |
|
2224
Hingham Institution for Saving
HIFS
$661M
| $172K | ﹤0.01% |
+867
| New | +$160K |
|
2225
Kearny Financial
KRNY
$610M
| $172K | ﹤0.01% |
12,965
-1,032
| -7% | -$13.9K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2019 Portfolio in Review
As of Q2 2019, Aperio Group held 3,091 positions worth $24.5B, up 5.7% from $23.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Aperio Group's Q2 2019 filing shows 800 new, 1,401 increased, 859 reduced and 15 closed positions. Its largest new stake was Dow Inc: 383,303 shares worth $18.9M. The largest sale was American National Group, Inc. Common Stock, an estimated $36.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q2 2019 buy was Dow Inc: 383,303 shares worth $18.9M.
- Aperio Group added most to AT&T in Q2 2019, an estimated $23.2M increase.
- Aperio Group's biggest Q2 2019 reduction was American National Group, Inc. Common Stock, cutting an estimated $36.1M.
- Aperio Group fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $6.06M.
- Aperio Group's ten largest holdings make up 16% of its $24.5B portfolio in Q2 2019.
- Aperio Group opened 800 new positions and closed 15 in Q2 2019.
- Aperio Group's portfolio value rose 5.7% quarter-over-quarter to $24.5B.
Based on Aperio Group's 13F filing for Q2 2019, filed 30 Jul 2019.